NASDAQ
No price data available for this timeframe.
NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.
Open
$3.62
Previous Close
$3.64
Day High
$3.64
Day Low
$3.51
52 Week High
$6.30
52 Week Low
$1.50